Gender differences in longitudinal relationships between depression and anxiety symptoms and inflammation in the health and retirement study

Psychoneuroendocrinology

Volumn 95, Issue , 2018, Pages 149-157

  Niles, Andrea N ^a,b   Smirnova, Mariya ^a,b   Lin, Joy ^a,b   O'Donovan, Aoife ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anxiety; C Reactive protein; Depression; Gender differences; Inflammation; Longitudinal; Sex differences

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANXIETY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DYSPHORIA; FEMALE; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; ANXIETY DISORDER; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; SEX FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; ANXIETY DISORDERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEX FACTORS;

EID: 85048461813     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2018.05.035     Document Type: Article

References (54)

1. Abu-Taha, M., Rius, C., Hermenegildo, C., Noguera, I., Cerda-Nicolas, J.-M., Issekutz, A.C., et al. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J. Immunol. 183:2 (2009), 1393–1402, 10.4049/jimmunol.0803157.
2. Allison, P.D., Handling missing data by maximum likelihood. SAS Global Forum, 2012, Statistical Horizons, Havenford, PA.
3. Beck, A.T., Epstein, N., Brown, G., Steer, R.A., An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 56:6 (1988), 893–897, 10.1037/0022-006X.56.6.893.
4. Bremmer, M.A., Beekman, A.T.F., Deeg, D.J.H., Penninx, B.W.J.H., Dik, M.G., Hack, C.E., Hoogendijk, W.J.G., Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. 106:3 (2008), 249–255, 10.1016/j.jad.2007.07.002.
5. Brydon, L., Edwards, S., Jia, H., Mohamed-Ali, V., Zachary, I., Martin, J.F., Steptoe, A., Psychological stress activates interleukin-1β gene expression in human mononuclear cells. Brain Behav. Immun. 19:6 (2005), 540–546, 10.1016/j.bbi.2004.12.003.
6. Capuron, L., Su, S., Miller, A.H., Bremner, J.D., Goldberg, J., Vogt, G.J., et al. Depressive symptoms and metabolic syndrome: Is inflammation the underlying link?. Biol. Psychiatry 64:10 (2008), 896–900, 10.1016/j.biopsych.2008.05.019.
7. Clarke, P., Fisher, G., House, J., Smith, J., Weir, D., Guide to Content of the HRS Psychosocial Leave-Behind Participant Lifestyle Questionnaires: 2004 & 2006. 2008, University of Michigan, Ann Arbor, MI.
8. Copeland, W.E., Shanahan, L., Worthman, C., Angold, A., Costello, E.J., Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol. Psychiatry 71:1 (2012), 15–21, 10.1016/j.biopsych.2011.09.023.
9. Crimmins, E., Faul, J., Kim, J.K., Guyer, H., Langa, K., Ofstedal, M.B., et al. Documentation of Biomarkers in the 2006 and 2008 Health and Retirement Study. 2013, Institute for Social Research, University of Michigan, Ann Arbor, MI.
10. Danner, M., Kasl, S.V., Abramson, J.L., Vaccarino, V., Association between depression and elevated C-reactive protein. Psychosom. Med. 65:3 (2003), 347–356, 10.1097/01.PSY.0000041542.29808.01.
11. Dantzer, R., Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 500:1–3 (2004), 399–411.
12. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:1 (2008), 46–56, 10.1038/nrn2297.
13. Department of Health and Human Services and U.S. Department of Agriculture, 2015-2020 Dietary Guidelines for Americans. 8th ed., 2015, USDA, Washington DC.
14. Deverts, D.J., Cohen, S., DiLillo, V.G., Lewis, C.E., Kiefe, C., Whooley, M., Matthews, K.A., Depressive symptoms, race, and circulating C-reactive protein: the coronary artery risk development in young adults (CARDIA) study. Psychosom. Med. 72:8 (2010), 734–741, 10.1097/PSY.0b013e3181ec4b98.
15. Duivis, H.E., Vogelzangs, N., Kupper, N., de Jong, P., Penninx, B.W.J.H., Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 38:9 (2013), 1573–1585.
16. Elovainio, M., Aalto, A.-M., Kivimaki, M., Pirkola, S., Sundvall, J., Loonqvist, J., Reunanen, A., Depression and C-reactive protein: population-based health 2000 study. Psychosom. Med. 71:4 (2009), 423–430.
17. Esler, M., Turbott, J., Schwarz, R., Leonard, P., Bobik, A., Skews, H., Jackman, G., The peripheral kinetics of norepinephrine in depressive illness. Arch. Gen. Psychiatry 39:3 (1982), 295–300, 10.1001/archpsyc.1982.04290030035006.
18. Ford, D.E., Erlinger, T.P., Depression and C-reactive protein in US adults. Arch Intern. Med. 164:9 (2004), 1010–1014.
19. Gimeno, D., Kivimäki, M., Brunner, E.J., Elovainio, M., Vogli, R.D., Steptoe, A., et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 39:3 (2009), 413–423, 10.1017/S0033291708003723.
20. Janszky, I., Ahnve, S., Lundberg, I., Hemmingsson, T., Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J. Am. Coll. Cardiol. 56:1 (2010), 31–37, 10.1016/j.jacc.2010.03.033.
21. Jokela, M., Virtanen, M., Batty, G.D., Kivimäki, M., Inflammation and specific symptoms of depression. JAMA Psychiatry 73:1 (2016), 87–88, 10.1001/jamapsychiatry.2015.1977.
22. Kawachi, I., Colditz, G.A., Ascherio, A., Rimm, E.B., Giovannucci, E., Stampfer, M.J., Willett, W.C., Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89:5 (1994), 1992–1997, 10.1161/01.CIR.89.5.1992.
23. Kawachi, I., Sparrow, D., Vokonas, P.S., Weiss, S.T., Symptoms of anxiety and risk of coronary heart disease. The normative aging study. Circulation 90:5 (1994), 2225–2229, 10.1161/01.CIR.90.5.2225.
24. Kessler, R.C., Chiu, W.T., Demler, O., Walters, E.E., Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62:6 (2005), 617–627, 10.1001/archpsyc.62.6.617.
25. Khandaker, G.M., Pearson, R.M., Zammit, S., Lewis, G., Jones, P.B., Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71:10 (2014), 1121–1128, 10.1001/jamapsychiatry.2014.1332.
26. Khandaker, G.M., Stochl, J., Zammit, S., Goodyer, I., Lewis, G., Jones, P.B., Childhood inflammatory markers and intelligence as predictors of subsequent persistent depressive symptoms: a longitudinal cohort study. Psychol. Med., 2017, 1–12, 10.1017/S0033291717003038.
27. Köhler-Forsberg, O., Buttenschøn, H.N., Tansey, K.E., Maier, W., Hauser, J., Dernovsek, M.Z., et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav. Immun. 62 (2017), 344–350, 10.1016/j.bbi.2017.02.020.
28. Ladwig, K.-H., Marten-Mittag, B., Löwel, H., Döring, A., Koenig, W., Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav. Immun. 17:4 (2003), 268–275, 10.1016/S0889-1591(03)00056-4.
29. Liukkonen, T., Räsänen, P., Jokelainen, J., Leinonen, M., Järvelin, M.-R., Meyer-Rochow, V.B., Timonen, M., The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 birth cohort study. Eur. Psychiatry 26:6 (2011), 363–369, 10.1016/j.eurpsy.2011.02.001.
30. Low, C.A., Cunningham, A.L., Kao, A.H., Krishnaswami, S., Kuller, L.H., Wasko, M.C.M., Association between C-reactive protein and depressive symptoms in women with rheumatoid arthritis. Biol. Psychol. 81:2 (2009), 131–134, 10.1016/j.biopsycho.2009.02.003.
31. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol., 16(1), 2016, 22, 10.1038/nri.2015.5.
32. Niles, A.N., Dour, H.J., Stanton, A.L., Roy-Byrne, P.P., Stein, M.B., Sullivan, G., et al. Anxiety and depressive symptoms and medical illness among adults with anxiety disorders. J. Psychosom. Res. 78:2 (2015), 109–115, 10.1016/j.jpsychores.2014.11.018.
33. O'Donovan, A., Hughes, B.M., Slavich, G.M., Lynch, L., Cronin, M.-T., O'Farrelly, C., Malone, K.M., Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion–biology relationships. Brain Behav. Immun. 24:7 (2010), 1074–1077, 10.1016/j.bbi.2010.03.003.
34. O'Donovan, A., Slavich, G.M., Epel, E.S., Neylan, T.C., Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging. Neurosci. Biobehav. Rev. 37:1 (2013), 96–108.
35. Onalan, G., Onalan, R., Selam, B., Akar, M., Gunenc, Z., Topcuoglu, A., Mood scores in relation to hormone replacement therapies during menopause: a prospective randomized trial. J. Exp. Med. 207 (2005), 223–231.
36. Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., Criqui, M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107:3 (2003), 499–511, 10.1161/01.CIR.0000052939.59093.45.
37. Penninx, B.W.J.H., Kritchevsky, S.B., Yaffe, K., Newman, A.B., Simonsick, E.M., Rubin, S., et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol. Psychiatry 54:5 (2003), 566–572, 10.1016/S0006-3223(02)01811-5.
38. Radloff, L.S., The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977), 385–401.
39. Scott, K.M., Bruffaerts, R., Tsang, A., Ormel, J., Alonso, J., Angermeyer, M.C., et al. Depression–anxiety relationships with chronic physical conditions: results from the world mental health surveys. J. Affect. Disord. 103:1 (2007), 113–120, 10.1016/j.jad.2007.01.015.
40. Slavich, G.M., Irwin, M.R., From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol. Bull. 140:3 (2014), 774–815, 10.1037/a0035302.
41. Stewart, J.C., Rand, K.L., Muldoon, M.F., Kamarck, T.W., A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav. Immun. 23:7 (2009), 936–944, 10.1016/j.bbi.2009.04.011.
42. Tayefi, M., Shafiee, M., Kazemi-Bajestani, S.M.R., Esmaeili, H., Darroudi, S., Khakpouri, S., et al. Depression and anxiety both associate with serum level of hs-CRP: a gender- stratified analysis in a population-based study. Psychoneuroendocrinology 81 (2017), 63–69, 10.1016/j.psyneuen.2017.02.035.
43. Toker, S., Shirom, A., Shapira, I., Berliner, S., Melamed, S., The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J. Occup. Health Psychol. 10:4 (2005), 344–362.
44. Valkanova, V., Ebmeier, K.P., Allan, C.L., CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 150:3 (2013), 736–744.
45. Veith, R.C., Lewis, N., Linares, O.A., Barnes, R.F., Raskind, M.A., Villacres, E.C., et al. Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 51:5 (1994), 411–422, 10.1001/archpsyc.1994.03950050071008.
46. Vetter, M.L., Wadden, T.A., Vinnard, C., Moore, R.H., Khan, Z., Volger, S., et al. Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. Int. J. Obes. 2005:37 (2013), S38–S43, 10.1038/ijo.2013.95.
47. Vogelzangs, N., Beekman, A.T.F., de Jonge, P., Penninx, B.W.J.H., Anxiety disor ders and inflammation in a large adult cohort. Transl. Psychiatry, 3(4), 2013, e249, 10.1038/tp.2013.27.
48. Vogelzangs, N., Duivis, H.E., Beekman, A.T.F., Kluft, C., Neuteboom, J., Hoogendijk, W., et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl. Psychiatry, 2(2), 2012, e79, 10.1038/tp.2012.8.
49. von Känel, R., Kudielka, B.M., Preckel, D., Hanebuth, D., Fischer, J.E., Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav. Immun. 20:1 (2006), 40–48, 10.1016/j.bbi.2005.03.013.
50. Wallace, R., Herzog, A.R., Ofstedal, M.B., Steffick, D., Fonda, S., Langa, K., Documentation of Affective Functioning Measures in the Health and Retirement Study. 2000, Institute for Social Research, University of Michigan, Ann Arbor, MI.
51. White, J., Kivimäki, M., Jokela, M., Batty, G.D., Association of inflammation with specific symptoms of depression in a general population of older people: the English longitudinal study of ageing. Brain Behav. Immun. 61 (2017), 27–30, 10.1016/j.bbi.2016.08.012.
52. Wium-Andersen, M.K., Ørsted, D.D., Nordestgaard, B.G., Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population. Br. J. Psychiatry 208:2 (2013), 138–145, 10.1192/bjp.bp.114.150870.
53. Yang, F.M., Jones, R.N., Measurement differences in depression: chronic health-related and sociodemographic effects in older Americans. Psychosom. Med. 70:9 (2008), 993–1004, 10.1097/PSY.0b013e31818ce4fa.
54. Zalli, A., Jovanova, O., Hoogendijk, W.J.G., Tiemeier, H., Carvalho, L.A., Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology 233:9 (2016), 1669–1678, 10.1007/s00213-015-3919-9.